Clinical study to compare the efficacyNew Rheumatil Gel with Diclofenac Gel inosteoarthritis and other muscloskeletal condition.
- Conditions
- Health Condition 1: M150- Primary generalized (osteo)arthritis
- Registration Number
- CTRI/2018/02/011783
- Lead Sponsor
- Dabur India Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1. Male or Female patients between 30-60 years of age. Adult patients of
both the sexes.
2. Patients suffering from mild to moderate OA involving knee joint.
3. The symptoms may consist of pain, swelling, tenderness and morning
stiffness, of one or more joints, which may have lasted for > 2 weeks.
4. Patients willing to participate in the study and willing to sign Informed
Consent Form
5. Patients on any other local medication for symptomatic management of
joint pains shall be included in the study after an adequate washout
period of 7 day.
6. Any other musculo-skeletal disorders with pain as the major presenting
symptom.
1. Patients with serious medical illness (HIV, Diabetes, SLE, Rheumatoid
Arthritis, Rheumatic Fever, Psoriatic Arthritis), surgical illness where
compliance is difficult.
2. Patients taking part in any other study.
3. Patients on any other medication for the treatment of arthritis other than
specified in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 weeks usage of the formulation with or without relief from the symptoms with <br/ ><br>1 week follow-up.Timepoint: 7 days & 14 days
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil